KCNIP3

This MedLibrary.org supplementary page on KCNIP3 is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Kv channel interacting protein 3, calsenilin
Identifiers
Symbols KCNIP3; CSEN; DREAM; KCHIP3; MGC18289
External IDs OMIM: 604662 MGI1929258 HomoloGene8382
Orthologs
Human Mouse
Entrez 30818 56461
Ensembl ENSG00000115041 n/a
Uniprot Q9Y2W7 n/a
Refseq NM_001034914 (mRNA)
NP_001030086 (protein)
NM_019789 (mRNA)
NP_062763 (protein)
Location Chr 2: 95.33 - 95.42 Mb n/a
Pubmed search [1] [2]

Kv channel interacting protein 3, calsenilin, also known as KCNIP3, is a human gene.[1]

This gene encodes a member of the family of voltage-gated potassium (Kv) channel-interacting proteins, which belong to the recoverin branch of the EF-hand superfamily. Members of this family are small calcium binding proteins containing EF-hand-like domains. They are integral subunit components of native Kv4 channel complexes that may regulate A-type currents, and hence neuronal excitability, in response to changes in intracellular calcium. The encoded protein also functions as a calcium-regulated transcriptional repressor, and interacts with presenilins. Alternatively spliced transcript variants encoding different isoforms have been described.[1]

Contents

See also

References

Further reading

  • Buxbaum JD, Choi EK, Luo Y, et al. (1998). "Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment.". Nat. Med. 4 (10): 1177–81. doi:10.1038/2673. PMID 9771752. 
  • Carrión AM, Mellström B, Naranjo JR (1998). "Protein kinase A-dependent derepression of the human prodynorphin gene via differential binding to an intragenic silencer element.". Mol. Cell. Biol. 18 (12): 6921–9. PMID 9819380. 
  • Carrión AM, Link WA, Ledo F, et al. (1999). "DREAM is a Ca2+-regulated transcriptional repressor.". Nature 398 (6722): 80–4. doi:10.1038/18044. PMID 10078534. 
  • An WF, Bowlby MR, Betty M, et al. (2000). "Modulation of A-type potassium channels by a family of calcium sensors.". Nature 403 (6769): 553–6. doi:10.1038/35000592. PMID 10676964. 
  • Leissring MA, Yamasaki TR, Wasco W, et al. (2000). "Calsenilin reverses presenilin-mediated enhancement of calcium signaling.". Proc. Natl. Acad. Sci. U.S.A. 97 (15): 8590–3. PMID 10900016. 
  • Buxbaum JD, Lilliehook C, Chan JY, et al. (2000). "Genomic structure, expression pattern, and chromosomal localization of the human calsenilin gene: no association between an exonic polymorphism and Alzheimer's disease.". Neurosci. Lett. 294 (3): 135–8. PMID 11072133. 
  • Ledo F, Carrión AM, Link WA, et al. (2001). "DREAM-alphaCREM interaction via leucine-charged domains derepresses downstream regulatory element-dependent transcription.". Mol. Cell. Biol. 20 (24): 9120–6. PMID 11094064. 
  • Jo DG, Kim MJ, Choi YH, et al. (2001). "Pro-apoptotic function of calsenilin/DREAM/KChIP3.". FASEB J. 15 (3): 589–91. doi:10.1096/fj.00-0541fje. PMID 11259376. 
  • Choi EK, Zaidi NF, Miller JS, et al. (2001). "Calsenilin is a substrate for caspase-3 that preferentially interacts with the familial Alzheimer's disease-associated C-terminal fragment of presenilin 2.". J. Biol. Chem. 276 (22): 19197–204. doi:10.1074/jbc.M008597200. PMID 11278424. 
  • Osawa M, Tong KI, Lilliehook C, et al. (2001). "Calcium-regulated DNA binding and oligomerization of the neuronal calcium-sensing protein, calsenilin/DREAM/KChIP3.". J. Biol. Chem. 276 (44): 41005–13. doi:10.1074/jbc.M105842200. PMID 11535596. 
  • Cheng HY, Pitcher GM, Laviolette SR, et al. (2002). "DREAM is a critical transcriptional repressor for pain modulation.". Cell 108 (1): 31–43. PMID 11792319. 
  • Lilliehook C, Chan S, Choi EK, et al. (2002). "Calsenilin enhances apoptosis by altering endoplasmic reticulum calcium signaling.". Mol. Cell. Neurosci. 19 (4): 552–9. doi:10.1006/mcne.2001.1096. PMID 11988022. 
  • Takimoto K, Yang EK, Conforti L (2002). "Palmitoylation of KChIP splicing variants is required for efficient cell surface expression of Kv4.3 channels.". J. Biol. Chem. 277 (30): 26904–11. doi:10.1074/jbc.M203651200. PMID 12006572. 
  • Ledo F, Kremer L, Mellström B, Naranjo JR (2002). "Ca2+-dependent block of CREB-CBP transcription by repressor DREAM.". EMBO J. 21 (17): 4583–92. PMID 12198160. 
  • Zaidi NF, Berezovska O, Choi EK, et al. (2002). "Biochemical and immunocytochemical characterization of calsenilin in mouse brain.". Neuroscience 114 (1): 247–63. PMID 12207970. 
  • Sanz C, Horita M, Fernandez-Luna JL (2004). "Fas signaling and blockade of Bcr-Abl kinase induce apoptotic Hrk protein via DREAM inhibition in human leukemia cells.". Haematologica 87 (9): 903–7. PMID 12217801. 
  • Schrader LA, Anderson AE, Mayne A, et al. (2002). "PKA modulation of Kv4.2-encoded A-type potassium channels requires formation of a supramolecular complex.". J. Neurosci. 22 (23): 10123–33. PMID 12451113. 
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932. 
  • Hong YM, Jo DG, Lee MC, et al. (2003). "Reduced expression of calsenilin/DREAM/KChIP3 in the brains of kainic acid-induced seizure and epilepsy patients.". Neurosci. Lett. 340 (1): 33–6. PMID 12648752. 
  • Shibata R, Misonou H, Campomanes CR, et al. (2003). "A fundamental role for KChIPs in determining the molecular properties and trafficking of Kv4.2 potassium channels.". J. Biol. Chem. 278 (38): 36445–54. doi:10.1074/jbc.M306142200. PMID 12829703. 

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.


Wikipedia content modification information:

  • This page was last modified on 9 July 2008, at 08:52.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "KCNIP3".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.